AI's Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

AI's Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

0 Hinnangud
0
Osa
753 of 1070
Kestus
19 min
Keel
inglise
Vorming
Kategooria
Majandus ja ettevõtlus

Today's guest is Ramesh Durvasula, Senior Vice President of R&D IT at Lilly. Ramesh joins us on the program today to discuss AI's impact on the drug targeting process, particularly in helping pharmaceutical leaders like Lilly better predict what potential drugs to invest in for bringing to market and when. With increased certainty in drug targeting, Ramesh explains how AI capabilities are driving clinical trials to be used as an alternative form of healthcare. Visit emerj.com/beg1 to learn more about the practical steps for AI deployment for non-technical professionals.


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Proovi tasuta
Device Banner Block-copy 894x1036
Cover for AI's Impact on the Drug Targeting Process - with Ramesh Durvasula of Lilly

Muud podcastid, mis võivad sulle meeldida ...